Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Triosephosphate isomerase 1 pseudogene 2 (TPI1P2) is a processed, intronless pseudogene in the human genome with high sequence similarity to the functional TPI1 gene but contains mutations that prevent the synthesis of an active triosephosphate isomerase enzyme[1][2][4]. Pseudogenes such as TPI1P2 do not code for functional proteins, and no direct biological role or disease involvement is established for this locus. The functional triosephosphate isomerase enzyme is a key metabolic enzyme involved in glycolysis, but only the actual TPI1 gene encodes active protein; TPI1P2 does not[1][2][4].\n\nIf you seek structured information for a drug target, it should be based on the parent functional gene, TPI1, not TPI1P2, as TPI1P2 is a non-functional pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Triosephosphate isomerase 1 pseudogene 2 (TPI1P2).